All Insights
Showing 61 - 72 of 415
Life Sciences and Healthcare
Will a new European Biotech Act unlock the full potential of biotechnology in the EU?
Call for evidence on the upcoming legislation underlines the importance of the biotech sector for the EU economy
Regulatory and compliance
European Commission publishes new single market strategy to further develop the European market
Proposal to ease burdens on smaller businesses and lift barriers to trade and investment likely to have positive impact on
Intellectual property
European Parliament and Council reach provisional agreement on compulsory patent licensing for crisis management
The agreement emphasises the last resort nature of compulsory licensing but still needs to be adopted formally
Competition, antitrust and trade
What's in the UK and India's historic trade deal?
After years of on-off negotiation, the deal should unlock significant opportunities for businesses in both countries
Life Sciences and Healthcare
Can newly enacted UK rules simplifying approval for precision bred plants survive the EU reset?
Genetic tech regulations set to come into force in November but UK and EU agree dynamic alignment on agrifood products
Life Sciences and Healthcare
Will the UK government implement recommendations for the engineering biology sector?
Government responds to recommendations from Lords committee and Regulatory Horizons Council
Unified Patent Court
Infringement claim amendment allowed to include non-UPC territories after CJEU Electrolux decision
Munich local division decided amendment could not be made earlier so allowed Syngenta to extend claim to Czechia, Poland and
Artificial intelligence
Guardians of innovation: US businesses in Europe need to protect trade secrets in the age of AI
Dynamic AI-aware governance frameworks can help safeguard intellectual assets often worth billions of dollars
Life Sciences and Healthcare
Court of Appeal overturns English Patents Court and grants interim injunction to prevent 'at risk' generic launch
Patents Court found wrong to hold damages would be an adequate remedy for AstraZeneca
Intellectual property
European Council adopts negotiating mandate on patents for gene-edited plants
EU moves closer to regulatory change for gene-edited plants but still a long way to go
Intellectual property
Unified Patent Court's Milan Local Division confirms its jurisdiction over cross-border patent infringement claim
UPC applies landmark CJEU ruling again, affirming its ability to adjudicate infringement claims relating to non-UPC European Patents
